Aurora Cannabis Inc.

ACB Healthcare Drug Manufacturers Specialty & Generic

Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.

3.99 0.11 −2.68%
Market cap
$265.8M
P/E
0.0×
Fwd P/E
−783×
Dividend yield
—
F-score
4/9
Altman Z
−12.34
Beneish M
−2.53
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
4 4 3 4

+8 more TTM periods

ROE
(19.85%) (21.82%) (15.13%) (10.17%)
ROA
(15.19%) (16.82%) (10.88%) (7.47%)
ROIC
(5.58%) (7.98%) (8.26%) (3.88%)
Return on Tangible Assets
(23.74%) (26.81%) (15.94%) (10.46%)
Average Days of Receivables
51.59 50.75 43.27 47.12
Free Cash Flow per Share
(0.59) (0.45) (0.37) (0.21)
Free Cash Flow
(36.10) (25.30) (21.26) (12.09)
Capital Expenditures
(15.79) (15.52) (14.44) (13.72)
Other line items
Cash ROIC
(7.21%) (5.03%) (3.63%) (2.07%)
Accounts Receivable Turnover
7.24 7.39 7.97 8.29
Accounts Payable Turnover
2.11 2.97 3.55 4.59
Inventory Turnover
0.70 0.89 1.01 0.93
Average Days of Payables
141.96 100.39 101.61 88.49
Days of Inventory on Hand
468.48 347.40 344.37 398.07
Tax Rate
0.06 0.04 0.09 0.16
Research and Development Expense of Revenue
1.97% 1.25% 1.02% 0.94%
Selling, General and Administrative Expense of Revenue
58.29% 54.12% 48.40% 48.68%
Share Based Compensation of Revenue
2.00% 2.27% 2.43% 3.04%
Interest Coverage
(70.51) (25.80) (7.73) (3.84)
Operating CF/Net income
0.25 0.11 0.11 (0.04)
Depreciation/Fixed assets
0.11 0.15 0.11 0.10
Capex/Depreciation
(1.38) (1.19) (0.70) (0.69)
Revenue per Share
3.40 4.09 4.71 4.65
Operating CF per Share
(0.33) (0.17) (0.12) 0.03
Capex per Share
(0.26) (0.27) (0.25) (0.24)
Capex to Sales
0.08 0.07 0.05 0.05

Fold the line items

Columns are period end dates